Clinical Trials Browser

INDUSTRY × Interventional × XMAB-2513 × Clear all

NCT00606645 2014-04-21

Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma

Phase 1 Completed

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic